RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS

Advisory Board of Russian Society of Cardiology (RSC), Russian National Atherosclerosis Society (RNAS), Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCRSP)

Saved in:
Bibliographic Details
Main Author: Advisory Board
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2017-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2320
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849341751071866880
author Advisory Board
author_facet Advisory Board
author_sort Advisory Board
collection DOAJ
description Advisory Board of Russian Society of Cardiology (RSC), Russian National Atherosclerosis Society (RNAS), Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCRSP)
format Article
id doaj-art-2b77a875a7ad4e39bfc3b7a58d9c3515
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2017-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-2b77a875a7ad4e39bfc3b7a58d9c35152025-08-20T03:43:34Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202017-06-0105859010.15829/1560-4071-2017-5-85-902061RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTSAdvisory Board0Board of Russian Society of Cardiology (RSC); Russian National Atherosclerosis Society (RNAS); Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCRSP)Advisory Board of Russian Society of Cardiology (RSC), Russian National Atherosclerosis Society (RNAS), Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCRSP)https://russjcardiol.elpub.ru/jour/article/view/2320fourierevolocumabhypolipidemic therapy
spellingShingle Advisory Board
RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
Российский кардиологический журнал
fourier
evolocumab
hypolipidemic therapy
title RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
title_full RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
title_fullStr RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
title_full_unstemmed RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
title_short RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS
title_sort results of the clinical trial fourier new opportunities for treatment of very high cardiovascular risk patients
topic fourier
evolocumab
hypolipidemic therapy
url https://russjcardiol.elpub.ru/jour/article/view/2320
work_keys_str_mv AT advisoryboard resultsoftheclinicaltrialfouriernewopportunitiesfortreatmentofveryhighcardiovascularriskpatients